FindTrial
Sign In

Can serum value of NT-proBNP be used in predicting patient outcome for those with preeclampsia admitted to ICU

Serum NT-proBNP (N-terminal propeptide Brain-type Natriuretic Peptide) as a Prognostic Marker in Patients with Preeclampsia admitted to Intensive Care Unit - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/053056
Enrollment
60
Registered
2023-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O14- Pre-eclampsia

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

UCMS and GTB Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All preeclamptic obstetric patients (pregnant or within 6 weeks postdelivery), admitted to our multidisciplinary ICU will be included. Diagnosis of preeclampsia will be made as per existing guidelines of American College of Obstetricians and Gynaecologists

Exclusion criteria

Exclusion criteria: Those with history of prior cardiac disease or renal disease will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
DeathTimepoint: Will be evaluated daily, starting from day of admission in ICU till end of hospital stay.—

Secondary

MeasureTime frame
Duration of ICU stay (days)Timepoint: From day of ICU admission till discharge/death in ICU—

Countries

India

Contacts

Public ContactDr Divya Gupta

University College of Medical Sciences and GTB Hospital

drashatyagi@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026